An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of pharmacology"
DOI: 10.1016/j.ejphar.2021.174635
Abstract: Dual activation of the glucagon-like peptide 1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor has potential as a novel strategy for treatment of diabesity. Here, we created a hybrid peptide which we named… read more here.
Keywords: oral glp; fat fed; gip; high fat ... See more keywords